Research Article
A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas
Table 1
The clinical characteristics of included patients in TCGA and CGGA.
| | Characteristic | TCGA-LGG | CGGA (mRNAseq_325) | CGGA (mRNAseq_693) | |
| | 461 | 302 | 636 | | | Gender, (%) | | | | 0.254 | | Female | 186 (13.7%) | 113 (8.3%) | 270 (19.9%) | | | Male | 236 (17.4%) | 189 (13.9%) | 365 (26.9%) | | | Grade, (%) | | | | <0.001 | | II | 199 (14.7%) | 97 (7.2%) | 171 (12.6%) | | | III | 223 (16.4%) | 72 (5.3%) | 243 (17.9%) | | | IV | 0 (0%) | 129 (9.5%) | 222 (16.4%) | | | IDH status, (%) | | | | <0.001 | | Mutant | 196 (17.3%) | 162 (14.3%) | 328 (28.9%) | | | Wildtype | 48 (4.2%) | 139 (12.3%) | 260 (22.9%) | | | Codel 1p/19q, (%) | | | | 0.121 | | Codel | 71 (6.4%) | 62 (5.6%) | 137 (12.3%) | | | Noncodel | 177 (15.9%) | 232 (20.8%) | 435 (39%) | | | Diagnosis age, median (IQR) | 41 (33, 53) | 42 (36, 51) | 43 (34, 51) | 0.696 |
|
|
IDH: isocitrate dehydrogenase; IQR: interquartile range; TCGA: The Cancer Genome Atlas; CGGA: Chinese Glioma Genome Atlas.
|
